HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-FEB-21 7LQD TITLE STRUCTURE OF HUMAN MPS1 (TTK) COVALENTLY BOUND TO RMS-07 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK OR MONOPOLAR SPINDLE 1 COMPND 3 KINASE; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 518-807; COMPND 6 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE,PYT; COMPND 7 EC: 2.7.12.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTK, MPS1, MPS1L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.S.SANTIAGO,C.V.DOS REIS,R.A.M.SERAFIM,K.B.MASSIRER,P.ARRUDA, AUTHOR 2 A.M.EDWARDS,R.M.COUNAGO,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 4 18-OCT-23 7LQD 1 REMARK REVDAT 3 09-MAR-22 7LQD 1 JRNL REVDAT 2 23-FEB-22 7LQD 1 JRNL REVDAT 1 16-FEB-22 7LQD 0 JRNL AUTH R.A.M SERAFIM,A.DA SILVA SANTIAGO,M.P.SCHWALM,Z.HU, JRNL AUTH 2 C.V.DOS REIS,J.E.TAKARADA,P.MEZZOMO,K.B.MASSIRER,M.KUDOLO, JRNL AUTH 3 S.GERSTENECKER,A.CHAIKUAD,L.ZENDER,S.KNAPP,S.LAUFER, JRNL AUTH 4 R.M.COUNAGO,M.GEHRINGER JRNL TITL DEVELOPMENT OF THE FIRST COVALENT MONOPOLAR SPINDLE KINASE 1 JRNL TITL 2 (MPS1/TTK) INHIBITOR. JRNL REF J.MED.CHEM. V. 65 3173 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35167750 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01165 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 28817 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1523 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2072 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.3270 REMARK 3 BIN FREE R VALUE SET COUNT : 137 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2137 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 134 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.84000 REMARK 3 B22 (A**2) : -2.63000 REMARK 3 B33 (A**2) : 1.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.137 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.116 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.930 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7LQD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000254834. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979180 REMARK 200 MONOCHROMATOR : CRYOGENICALLY-COOLED SINGLE REMARK 200 CRYSTAL SI(220) SIDE BOUNCE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30369 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 29.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9.200 REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.68500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 5N84 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M MAGNESIUM CHLORIDE HEXAHYDRATE, REMARK 280 0.05 M SODIUM CITRATE TRIBASIC, 0.1 M BIS-TRIS PROPANE, PH 7.8, REMARK 280 22.5% PEG SMEAR HIGH, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.97350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 51.56850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.92550 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.97350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 51.56850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.92550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.97350 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 51.56850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.92550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.97350 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 51.56850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.92550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 139.89400 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 103.13700 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 HIS A 497 REMARK 465 HIS A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 465 SER A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 VAL A 506 REMARK 465 ASP A 507 REMARK 465 LEU A 508 REMARK 465 GLY A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 ASN A 512 REMARK 465 LEU A 513 REMARK 465 TYR A 514 REMARK 465 VAL A 679 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 515 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 523 CZ NH1 NH2 REMARK 470 LYS A 529 NZ REMARK 470 LYS A 538 CE NZ REMARK 470 LYS A 546 CE NZ REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 GLN A 563 CD OE1 NE2 REMARK 470 LYS A 577 NZ REMARK 470 GLN A 580 CG CD OE1 NE2 REMARK 470 LYS A 614 NZ REMARK 470 LYS A 615 CG CD CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 VAL A 678 CG1 CG2 REMARK 470 LYS A 680 CG CD CE NZ REMARK 470 LYS A 710 CG CD CE NZ REMARK 470 GLU A 753 CG CD OE1 OE2 REMARK 470 LYS A 777 CE NZ REMARK 470 GLN A 794 CD OE1 NE2 REMARK 470 THR A 795 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 647 52.37 -153.89 REMARK 500 REMARK 500 REMARK: NULL DBREF 7LQD A 519 808 UNP P33981-2 TTK-2_HUMAN 518 807 SEQADV 7LQD MET A 496 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD HIS A 497 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD HIS A 498 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD HIS A 499 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD HIS A 500 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD HIS A 501 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD HIS A 502 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD SER A 503 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD SER A 504 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD GLY A 505 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD VAL A 506 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD ASP A 507 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD LEU A 508 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD GLY A 509 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD THR A 510 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD GLU A 511 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD ASN A 512 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD LEU A 513 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD TYR A 514 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD PHE A 515 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD GLN A 516 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD SER A 517 UNP P33981-2 EXPRESSION TAG SEQADV 7LQD MET A 518 UNP P33981-2 EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN SER TRP SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY THR VAL ASN TYR MET SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN SEQRES 24 A 313 THR HIS PRO VAL ASN GLN MET ALA LYS GLY THR THR GLU SEQRES 25 A 313 GLU HET YB4 A 901 45 HET GOL A 902 6 HET GOL A 903 6 HET GOL A 904 6 HET GOL A 905 6 HET GOL A 906 6 HET TOE A 907 11 HETNAM YB4 ~{N}-(2,6-DIETHYLPHENYL)-2-[[4-(4-METHYLPIPERAZIN-1- HETNAM 2 YB4 YL)-2-(PROPANOYLAMINO)PHENYL]AMINO]-5,6- HETNAM 3 YB4 DIHYDROPYRIMIDO[4,5-E]INDOLIZINE-7-CARBOXAMIDE HETNAM GOL GLYCEROL HETNAM TOE 2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 YB4 C35 H42 N8 O2 FORMUL 3 GOL 5(C3 H8 O3) FORMUL 8 TOE C7 H16 O4 FORMUL 9 HOH *134(H2 O) HELIX 1 AA1 ASP A 561 SER A 582 1 22 HELIX 2 AA2 LEU A 609 LYS A 616 1 8 HELIX 3 AA3 ASP A 620 HIS A 641 1 22 HELIX 4 AA4 LYS A 649 ALA A 651 5 3 HELIX 5 AA5 PRO A 691 MET A 698 1 8 HELIX 6 AA6 SER A 712 GLY A 730 1 19 HELIX 7 AA7 ASN A 739 ASP A 749 1 11 HELIX 8 AA8 GLU A 761 LEU A 772 1 12 HELIX 9 AA9 SER A 781 ALA A 787 1 7 HELIX 10 AB1 HIS A 788 ILE A 793 1 6 SHEET 1 AA1 6 GLN A 516 VAL A 520 0 SHEET 2 AA1 6 ARG A 523 GLY A 534 -1 O TYR A 525 N MET A 518 SHEET 3 AA1 6 SER A 537 LEU A 543 -1 O GLN A 541 N LEU A 528 SHEET 4 AA1 6 ILE A 549 ASN A 556 -1 O TYR A 554 N LYS A 538 SHEET 5 AA1 6 TYR A 597 MET A 602 -1 O MET A 602 N ALA A 551 SHEET 6 AA1 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601 SHEET 1 AA2 3 ILE A 607 ASP A 608 0 SHEET 2 AA2 3 PHE A 653 VAL A 656 -1 O ILE A 655 N ILE A 607 SHEET 3 AA2 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 LINK SG CYS A 604 C35 YB4 A 901 1555 1555 1.71 CRYST1 69.947 103.137 113.851 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014297 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009696 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008783 0.00000